Full approval from the FDA: for the corona vaccine from the American pharmaceutical giant Pfizer

First vaccine receives full approval from the FDA: The US Food and Drug Administration on Monday granted full approval for the corona vaccine from the American pharmaceutical giant Pfizer and from the German BioNTech - after so far it and the other vaccines have only been given emergency approval. It is a kind of "declaration of allegiance" that the authorities in the US and the rest of the world, as well as Pfizer itself, hope will provide greater confidence in vaccines against the virus, and may to some extent reduce the phenomenon of stubborn opposition to it.
Pfizer's vaccine, it will be recalled, was approved by the FDA in December last year, and since then more than 200 million of its doses have been distributed in the United States and hundreds of millions more have been distributed worldwide. The vaccine will continue to be given under emergency clearance. "The public can be confident that this vaccine meets the high standards of safety, efficacy and production quality - that the FDA requires for an approved product," said the Acting Commissioner for Food and Drug Administration, Dr. Janet Woodcock. . "The milestone we reached today brings us one step closer to changing the course of this plague in the United States."
The U.S. is now the first country in the world to give, according to Pfizer, full and permanent approval for the company's corona vaccine.
The company said the updated data show that after the second dose its vaccine effectiveness in preventing infection is 91%, a slight decrease compared to the 95% reported when the FDA granted the emergency approval in December. These data, it should be emphasized, do not refer to the decrease in vaccine efficacy observed in data in Israel and the rest of the world after a few months of receiving the second dose - a decrease that Pfizer itself announced it noticed, and said it would act to obtain a third and updated FDA approval.